2,500,467 Shares in Core Scientific, Inc. $CORZ Purchased by Cooper Creek Partners Management LLC

Cooper Creek Partners Management LLC bought a new stake in shares of Core Scientific, Inc. (NASDAQ:CORZ) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 2,500,467 shares of the company’s stock, valued at approximately $37,407,000. Core Scientific accounts for approximately 1.3% of Cooper Creek Partners Management LLC’s investment portfolio, making the stock its 28th biggest holding.

Other hedge funds have also recently added to or reduced their stakes in the company. Allworth Financial LP increased its position in Core Scientific by 206.5% in the 3rd quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock worth $25,000 after buying an additional 950 shares during the period. Larson Financial Group LLC boosted its position in shares of Core Scientific by 936.7% in the fourth quarter. Larson Financial Group LLC now owns 1,866 shares of the company’s stock valued at $27,000 after acquiring an additional 1,686 shares during the period. Osaic Holdings Inc. boosted its position in shares of Core Scientific by 112.1% in the second quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock valued at $34,000 after acquiring an additional 1,066 shares during the period. Danske Bank A S acquired a new stake in shares of Core Scientific in the fourth quarter worth $36,000. Finally, Russell Investments Group Ltd. grew its stake in shares of Core Scientific by 61.9% in the second quarter. Russell Investments Group Ltd. now owns 3,942 shares of the company’s stock worth $67,000 after acquiring an additional 1,507 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the stock. Cantor Fitzgerald boosted their target price on shares of Core Scientific from $25.00 to $29.00 and gave the stock an “overweight” rating in a research report on Thursday, April 9th. Canaccord Genuity Group set a $30.00 price target on shares of Core Scientific in a report on Friday, May 8th. Jefferies Financial Group raised their price target on shares of Core Scientific from $24.00 to $37.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. BTIG Research boosted their price objective on shares of Core Scientific from $33.00 to $38.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. Finally, Freedom Capital raised shares of Core Scientific to a “hold” rating in a research report on Monday, June 15th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Core Scientific currently has an average rating of “Moderate Buy” and a consensus price target of $30.39.

Insiders Place Their Bets

In other Core Scientific news, insider Todd M. Duchene sold 10,000 shares of Core Scientific stock in a transaction on Monday, July 6th. The shares were sold at an average price of $22.63, for a total transaction of $226,300.00. Following the sale, the insider owned 2,023,426 shares in the company, valued at $45,790,130.38. The trade was a 0.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders have sold a total of 80,000 shares of company stock worth $2,011,800 in the last 90 days. 1.70% of the stock is owned by insiders.

Core Scientific Trading Down 5.1%

Shares of NASDAQ:CORZ opened at $22.75 on Friday. Core Scientific, Inc. has a 1-year low of $12.60 and a 1-year high of $30.46. The firm has a market capitalization of $7.23 billion, a PE ratio of -19.96 and a beta of 5.50. The business’s 50 day moving average is $25.42 and its 200-day moving average is $20.68.

Core Scientific (NASDAQ:CORZ) last released its quarterly earnings data on Wednesday, May 6th. The company reported ($1.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($1.04). The firm had revenue of $115.24 million during the quarter, compared to analyst estimates of $117.04 million. The company’s revenue for the quarter was up 44.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.25 EPS. On average, sell-side analysts predict that Core Scientific, Inc. will post 0.08 EPS for the current year.

About Core Scientific

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.